Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 380 citing Ginsburg: Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. (0.09 sec) 

The antiphospholipid syndrome


JS Levine, D Branch, J Rauch - The New England Journal of Medicine ( …, 2002 - cme.nejm.org
From the Department of Medicine, Section of Nephrology, University of Chicago, Chicago
(JSL); the Department of Obstetrics and Gynecol- ogy, University of Utah, Salt Lake City
(DWB); and the Department of Medicine, Division of Rheumatology, Research Institute of ...
Cited by 828 - Related articles - View as HTML - BL Direct - All 8 versions

Risk factors for venous thromboembolism

- ahajournals.org
FA Anderson Jr, FA Spencer - Circulation, 2003 - Am Heart Assoc
Until the 1990s, venous thromboembolism (VTE) was viewed primarily as a complication of hospitalization
for major surgery (or associated with the late stage of terminal illness). However, recent trials
in patients hospitalized with a wide variety of acute medical illnesses have demonstrated ...
Cited by 351 - Related articles - BL Direct - All 11 versions

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin …

- bloodjournal.org
M Galli, D Luciani, G Bertolini, T Barbui - Blood, 2003 - Am Soc Hematology
Antiphospholipid antibodies are a heterogeneous family of immunoglobulins that includes, among
others, lupus anticoagulants and anticardiolipin antibodies. Lupus anticoagulants behave as
acquired inhibitors of coagulation, prolonging phospholipid-dependent in vitro ...
Cited by 345 - Related articles - BL Direct - All 7 versions

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid …


G Finazzi, V Brancaccio, M Moia, N Ciavarella, MG … - The American journal of …, 1996 - Elsevier
Thirty-four patients developed a thrombotic complication, with a total incidence of 2.5%
patient-years. Multivariate logistic regression analysis identified two independent risk factors
for thrombotic events: a previous thrombosis (RR 4.9; 95% Cl, 1.76 to 13.7; P < 0.005) ...
Cited by 301 - Related articles - BL Direct - All 7 versions

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

- nih.gov [PDF] 
R Simantov, JM LaSala, SK Lo, AE … - Journal of Clinical …, 1995 - pubmedcentral.nih.gov
Circulating antiphospholipid antibodies (aPL) are associ- ated with a syndrome of
thrombosis, recurrent fetal loss, and thrombocytopenia. We have demonstrated the activation
of cultured human umbilical vein endothelial cells (HUVEC) by IgG from patients with ...
Cited by 287 - Related articles - BL Direct - All 6 versions

Antiphospholipid antibodies are directed against epitopes of oxidized …

- nih.gov [PDF] 
S Hörkkö, E Miller, E Dudl, P Reaven, LK … - Journal of Clinical …, 1996 - pubmedcentral.nih.gov
The optimal clinical management of patients with antiphos- pholipid antibody syndrome
(APS) is uncertain because of a lack of an underlying hypothesis to explain why antiphos- pholipid
autoantibodies (aPL) form to such ubiquitous com- pounds as phospholipids (PL). In this ...
Cited by 294 - Related articles - BL Direct - All 7 versions

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort …

- ahajournals.org
O Vaarala, M Manttari, V Manninen, L Tenkanen, M … - Circulation, 1995 - Am Heart Assoc
Methods and Results The sera to be studied were drawn at entry from middle-aged dyslipidemic
men (non–high-density lipoprotein cholesterol, 5.2 mmol/L) participating in the Helsinki Heart
Study, a 5-year coronary primary prevention trial with gemfibrozil. Samples were tested ...
Cited by 264 - Related articles - BL Direct - All 5 versions

Anticardiolipin antibodies predict early recurrence of thromboembolism and death …


MD Schulman… - The American journal of medicine, 1998 - Elsevier
Results: Among the 412 patients with a first episode of venous thromboembolism the risk of recurrence
was 29% in patients with anticardiolipin antibodies and 14% in those without antibodies (P =
0.0013). In those with antibodies, there was an increased risk during the first 6 months ...
Cited by 232 - Related articles - BL Direct - All 3 versions

Antiphospholipid thrombosis syndromes

- hem-aids.ru [PDF] 
RL Bick - Hematology/oncology clinics of North America, 2003 - Elsevier
Antiphospholipid thrombosis syndromes, which include not only the lupus anticoagulant (LA)
and anticardiolipin antibodies (ACLAs) but also more recently recognized “subgroups” of antiphospholipid
antibodies (antibodies against beta-2-glycoprotein-I [B-2-GP-I]) and antibodies to ...
Cited by 228 - Related articles - BL Direct - All 14 versions

Epidemiology of the antiphospholipid antibody syndrome


M Petri - Journal of Autoimmunity, 2000 - Elsevier
The prevalence of antiphospholipid antibodies in normals and SLE patients is reviewed. The
frequency of complications of antiphospholipid antibodies (thrombosis, pregnancy morbidity)
in the literature and in the Hopkins Lupus Cohort is summarized.
Cited by 190 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google